Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking.
paper
Primary
Public
Unavailable
- Authors
- Bierut, L J; Rice, J P; Edenberg, H J; Goate, A; Foroud, T; Cloninger, C R; Begleiter, H; Conneally, P M; Crowe, R R; Hesselbrock, V; Li, T K; Nurnberger, J I; Porjesz, B; Schuckit, M A; Reich, T
- Year
- 2000
- Journal
- American journal of medical genetics
- PMID
- 10710227
- DOI
- 10.1002/(sici)1096-8628(20000214)90:4<299::aid-ajmg7>3.0.co;2-y
A recent study showed an association between the dopamine D2 receptor gene (DRD2) and smoking. The purpose of this study was to determine if the familial transmission of smoking is linked to variation at the DRD2 locus in a genetically informative sample. Subjects were identified in alcohol treatment centers and their relatives were recruited for study. All subjects were interviewed to assess alcohol dependence, smoking habits, and psychiatric disorders. Two polymorphisms within the DRD2 gene were analyzed, including the TaqIA polymorphism. The sample consisted of 138 nuclear families with at least one offspring with habitual smoking, and analysis was by the transmission disequilibrium test (TDT), which avoids problems due to population stratification. There was no significant difference in the frequency between DRD2 alleles transmitted and not transmitted to habitual smokers. There also was no evidence for unequal transmission of DRD2 alleles for the phenotypes "ever smoker" or comorbid alcohol dependence and habitual smoking. This study does not support linkage of the DRD2 with smoking.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The collaborative study on the genetics of alcoholism: Genetics. | Johnson EC et al. | — | 2023 | → |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | — | 2021 | → |
| Trace Amines and Their Receptors. | Gainetdinov RR et al. | — | 2018 | → |
| Association of ankyrin repeats & kinase domain containing 1 (<i>ANKK1</i>) gene polymorphism with co-morbid alcohol & nicotine dependence: A pilot study from a tertiary care treatment centre in north India. | Quraishi R et al. | — | 2017 | → |
| CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. | Tomaz PR et al. | — | 2015 | → |
| Identification and fine mapping of qPH6, a novel major quantitative trait locus for plant height in rice | Yuanyuan et al. | — | 2015 | — |
| The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. | Ma Y et al. | — | 2015 | → |
| Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. | Ohmoto M et al. | — | 2014 | → |
| Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update. | Ohmoto M et al. | — | 2013 | → |
| Gene variants associated with antisocial behaviour: a latent variable approach. | Bentley MJ et al. | — | 2013 | → |
| TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. | Ducci F et al. | — | 2011 | → |
| Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. | Knott V et al. | — | 2010 | → |
| The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. | Clague J et al. | — | 2010 | → |
| Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. | Munafò MR et al. | — | 2009 | → |
| DAT genotype modulates brain and behavioral responses elicited by cigarette cues. | Franklin TR et al. | — | 2009 | → |
| Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? | Quaak M et al. | — | 2009 | → |
| Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. | Quaak M et al. | — | 2009 | → |
| Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. | Sieminska A et al. | — | 2009 | → |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | — | 2009 | → |
| Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. | Huang W et al. | — | 2009 | → |
| Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. | Chen X et al. | — | 2009 | → |
| Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. | Perkins KA et al. | — | 2008 | → |
| Neuroimaging, genetics and the treatment of nicotine addiction. | Ray R et al. | — | 2008 | → |
| A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups. | Fernander AF et al. | — | 2007 | → |
| Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. | Vandenbergh DJ et al. | — | 2007 | → |
| Genetics and smoking behavior. | Schnoll RA et al. | — | 2007 | → |
| Genetics and smoking cessation improving outcomes in smokers at risk. | Lerman CE et al. | — | 2007 | → |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | — | 2007 | → |
| Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. | David SP et al. | — | 2007 | → |
| RhoA, encoding a Rho GTPase, is associated with smoking initiation. | Chen X et al. | — | 2007 | → |
| The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. | Robinson JD et al. | — | 2007 | → |
| Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. | Segman RH et al. | — | 2007 | → |
| An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. | Timberlake DS et al. | — | 2006 | → |
| Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. | Brody AL et al. | — | 2006 | → |
| Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. | Dahl JP et al. | — | 2006 | → |
| Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. | Lerman C et al. | — | 2006 | → |
| Striatal dopamine D2/D3 receptor availability in male smokers. | Yang YK et al. | — | 2006 | → |
| Symbiotic relationship of pharmacogenetics and drugs of abuse. | Rutter JL | — | 2006 | → |
| The genetics of nicotine dependence: relationship to pancreatic cancer. | MacLeod SL et al. | — | 2006 | → |
| Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. | Swan GE et al. | — | 2005 | → |
| Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. | Erblich J et al. | — | 2005 | → |
| [Genetic basis of tobacco dependence]. | Barrueco M et al. | — | 2005 | → |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | — | 2005 | → |
| Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men. | Costa-Mallen P et al. | — | 2005 | → |
| Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. | Liu CM et al. | — | 2005 | → |
| Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. | Caron L et al. | — | 2005 | → |
| Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications. | Lentz F et al. | — | 2005 | → |
| The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. | Shields AE et al. | — | 2005 | → |
| Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. | Young RM et al. | — | 2004 | → |
| A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. | Bierut LJ et al. | — | 2004 | → |
| Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health. | Olsson C et al. | — | 2004 | → |
| Cigarette smoking and nicotine dependence. | Zbikowski SM et al. | — | 2004 | → |
| Genetics and drug use as a complex phenotype. | Lessov CN et al. | — | 2004 | → |
| Genetics of tobacco use. | Maserejian NN et al. | — | 2004 | → |
| Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. | Johnstone EC et al. | — | 2004 | → |
| Interacting effects of genetic predisposition and depression on adolescent smoking progression. | Audrain-McGovern J et al. | — | 2004 | → |
| Progress in searching for susceptibility loci and genes for smoking-related behaviour. | Li MD et al. | — | 2004 | → |
| Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. | Erblich J et al. | — | 2004 | → |
| The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. | Johnstone EC et al. | — | 2004 | → |
| D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. | Noble EP | — | 2003 | → |
| Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. | Lerman C et al. | — | 2003 | → |
| Elucidating the role of genetic factors in smoking behavior and nicotine dependence. | Lerman C et al. | — | 2003 | → |
| Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. | Swan GE et al. | — | 2003 | → |
| Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking. | Lee HS | — | 2003 | → |
| Genetic influences on smoking behavior and nicotine dependence: a review. | Yoshimasu K et al. | — | 2003 | → |
| Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. | Hwu HG et al. | — | 2003 | → |
| The genetic determinants of smoking. | Batra V et al. | — | 2003 | → |
| The genetics of smoking related behavior: a brief review. | Li MD | — | 2003 | → |
| Applying genetic approaches to the treatment of nicotine dependence. | Lerman C et al. | — | 2002 | → |
| Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. | Walton R et al. | — | 2001 | → |
| New directions in the genetic mechanisms underlying nicotine addiction. | Munafò M et al. | — | 2001 | → |
| Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. | Dagher A et al. | — | 2001 | → |
| Co-occurring risk factors for alcohol dependence and habitual smoking. | Bierut LJ et al. | — | 2000 | → |
| Polymorphisms in dopamine receptors: what do they tell us? | Wong AH et al. | — | 2000 | → |
| Polymorphisms in genes involved in neurotransmission in relation to smoking. | Arinami T et al. | — | 2000 | → |
| The dopamine D2 receptor (DRD2) gene-a genetic risk factor in heavy smoking? | Batra A et al. | — | 2000 | → |